Interleukin-10-induced MARCH1 mediates intracellular sequestration of MHC class II in monocytes

  • Eur J Immunol. 2008 May;38(5):1225-30. doi: 10.1002/eji.200737902.
Jacques Thibodeau  1 ,  Marie-Claude Bourgeois-Daigneault ,  Gabrielle Huppé ,  Jessy Tremblay ,  Angélique Aumont ,  Mathieu Houde ,  Eric Bartee ,  Alexandre Brunet ,  Marie-Elaine Gauvreau ,  Aude de Gassart ,  Evelina Gatti ,  Martin Baril ,  Maryse Cloutier ,  Séverine Bontron ,  Klaus Früh ,  Daniel Lamarre ,  Viktor Steimle
Affiliations
  • 1. Département de Microbiologie et Immunologie, Université de Montréal, Montréal, QC, Canada. [email protected]
Abstract

IL-10 is a potent anti-inflammatory cytokine interfering with antigen presentation by inducing the intracellular sequestration of MHC class II (MHC-II) molecules. Here we studied the contribution of membrane-associated RING-CH (MARCH) ubiquitin Ligase family members to the IL-10-induced down-regulation of MHC-II molecules. We found that MARCH1 and MARCH8 proteins are the most potent family members for the down-regulation of MHC-II surface expression in transfected cells, but only MARCH1 mRNA expression is strongly induced by IL-10 in human primary monocytes. We detected mono- and poly-ubiquitinated forms of MHC-II molecules both in IL-10-treated monocytes and in cells transfected with MARCH1. We also show direct interaction between MHC-II and MARCH1 molecules in co-immunoprecipitation assays. Finally, we found that siRNA-mediated knockdown of MARCH1 reverses IL-10-induced MHC-II down-regulation in primary monocytes. Thus, the immunosuppressive effect of IL-10 on antigen presentation is mediated through induced expression of MARCH1.